123 related articles for article (PubMed ID: 17803476)
1. Effect of N-acetylcysteine on renal function in patients with chronic kidney disease.
Mainra R; Gallo K; Moist L
Nephrology (Carlton); 2007 Oct; 12(5):510-3. PubMed ID: 17803476
[TBL] [Abstract][Full Text] [Related]
2. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Kimmel M; Butscheid M; Brenner S; Kuhlmann U; Klotz U; Alscher DM
Nephrol Dial Transplant; 2008 Apr; 23(4):1241-5. PubMed ID: 18174269
[TBL] [Abstract][Full Text] [Related]
3. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
[TBL] [Abstract][Full Text] [Related]
4. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
Merkle M; Sauter M; Argirov M; Wörnle M
Ren Fail; 2010 Jan; 32(1):85-90. PubMed ID: 20113272
[TBL] [Abstract][Full Text] [Related]
6. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylcysteine does not artifactually lower plasma creatinine concentration.
Haase M; Haase-Fielitz A; Ratnaike S; Reade MC; Bagshaw SM; Morgera S; Dragun D; Bellomo R
Nephrol Dial Transplant; 2008 May; 23(5):1581-7. PubMed ID: 18202091
[TBL] [Abstract][Full Text] [Related]
8. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.
Poletti PA; Saudan P; Platon A; Mermillod B; Sautter AM; Vermeulen B; Sarasin FP; Becker CD; Martin PY
AJR Am J Roentgenol; 2007 Sep; 189(3):687-92. PubMed ID: 17715118
[TBL] [Abstract][Full Text] [Related]
9. N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C.
Alioglu E; Saygi S; Turk U; Kirilmaz B; Tuzun N; Duman C; Tengiz I; Yildiz S; Ercan E
Cardiovasc Ther; 2013 Jun; 31(3):168-73. PubMed ID: 22212518
[TBL] [Abstract][Full Text] [Related]
10. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
11. Does intravenous or oral high-dose N-acetylcysteine in addition to saline prevent contrast-induced nephropathy assessed by cystatin C?
Erturk M; Uslu N; Gorgulu S; Akbay E; Kurtulus G; Akturk IF; Akgul O; Surgit O; Uzun F; Gul M; Isiksacan N; Yildirim A
Coron Artery Dis; 2014 Mar; 25(2):111-7. PubMed ID: 24365793
[TBL] [Abstract][Full Text] [Related]
12. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
[TBL] [Abstract][Full Text] [Related]
13. Serum cystatin C level as a potentially good marker for impaired kidney function.
Uzun H; Ozmen Keles M; Ataman R; Aydin S; Kalender B; Uslu E; Simsek G; Halac M; Kaya S
Clin Biochem; 2005 Sep; 38(9):792-8. PubMed ID: 16005452
[TBL] [Abstract][Full Text] [Related]
14. Renal protection by radical scavenging in cardiac surgery patients.
Fischer UM; Tossios P; Mehlhorn U
Curr Med Res Opin; 2005 Aug; 21(8):1161-4. PubMed ID: 16083524
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation.
Hilmi IA; Peng Z; Planinsic RM; Damian D; Dai F; Tyurina YY; Kagan VE; Kellum JA
Nephrol Dial Transplant; 2010 Jul; 25(7):2328-33. PubMed ID: 20179007
[TBL] [Abstract][Full Text] [Related]
16. N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients.
Rehman T; Fought J; Solomon R
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1610-4. PubMed ID: 18667743
[TBL] [Abstract][Full Text] [Related]
17. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.
Tepel M; van der Giet M; Schwarzfeld C; Laufer U; Liermann D; Zidek W
N Engl J Med; 2000 Jul; 343(3):180-4. PubMed ID: 10900277
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
[TBL] [Abstract][Full Text] [Related]
19. Potentially detrimental effects of N-acetylcysteine on renal function in knee arthroplasty.
Laisalmi-Kokki M; Pesonen E; Kokki H; Valta P; Pitkänen M; Teppo AM; Honkanen E; Lindgren L
Free Radic Res; 2009 Jul; 43(7):691-6. PubMed ID: 19526394
[TBL] [Abstract][Full Text] [Related]
20. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
